ARCHIVES

NCI Chips In $2 Million For AACR Meeting; Advisors, Senior Staff Not Consulted.

This article is from The Cancer Letter archive.

Vol. 29 No. | August 12, 2003

Download PDF Visit The Full Archive

Related Articles

Amgen Claimed QOL Benefit Despite FDA Label Change.

May 18, 2007

Orders Still Accepted For 20th Anniversary Special Publication

July 19, 1991

Samuel Waksal Resigns From ImClone Following Unimpressive ASCO Presentation

May 24, 2002

Lederberg Appointment As Panel Chairman Confirmed; Bernard Fisher will Be Names To The Other Vacancy

November 30, 1979

In Brief: Goldman Named Director, Albert Einstein Cancer Center; Wiernik Resumes Post

October 20, 1995

NIH Forming Special Emphasis Panel To Review Clinical Oncology Grants

September 18, 1998